Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:1183-1185 (19 November), doi:10.1136/bmj.38663.459039.7C
Ilkka Kalliala, researcher1, Ahti Anttila, research director2, Eero Pukkala, director of statistics3, Pekka Nieminen, senior consultant1
1 Department of Obstetrics and Gynaecology, Helsinki University Central Hospital, Box 140, FIN-00029, Helsinki, Finland, 2 Mass Screening Registry, Finnish Cancer Registry, Liisankatu 21 B, FIN-00170, Helsinki, Finland, 3 Finnish Cancer Registry, Liisankatu 21 B, FIN-00170, Helsinki, Finland
Correspondence to: I Kalliala ilkka.kalliala{at}helsinki.fi
Objective To study the long term risk of cervical and other cancers after treatment for cervical intraepithelial neoplasia.
Design Retrospective cohort study.
Setting University Hospital, Helsinki, Finland.
Participants 7564 women treated for cervical intraepithelial neoplasia during 1974 and 2001 and followed up through the Finnish cancer registry until 2003.
Main outcome measures Standardised incidence ratio for cervical cancer and other cancers.
Results During follow-up 22 cases of invasive cervical cancer occurred in women treated for cervical intraepithelial neoplasia (standardised incidence ratio 2.8, 95% confidence interval 1.7 to 4.2). The highest risk was during the second decade (10 cases observed: 3.1, 1.5 to 5.7). The standardised incidence ratio for cervical intraepithelial cancer type 1 was 3.1 (1.4 to 6.2) and for type 2 was 3.7 (0.9 to 10.7).
Conclusions The risk of cervical cancer in the first 20 years after treatment for cervical intraepithelial neoplasia is higher than in the average population. The risk of smoking related cancers is also increased.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses